Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response

Background: Increasing evidence illustrated that m6A regulator-mediated modification plays a crucial role in regulating tumor immune and angiogenesis microenvironment. And the combination of immune checkpoint inhibitor and anti-angiogenic therapy has been approved as new first-line therapy for advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiang-Xu, Wu, Li-Hong, Dou, Qiong-Yi, Ai, Liping, Lu, Yajie, Deng, Shi-Zhou, Liu, Qing-Qing, Ji, Hongchen, Zhang, Hong-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634552/
https://www.ncbi.nlm.nih.gov/pubmed/36339715
http://dx.doi.org/10.3389/fmolb.2022.1034928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634552/
https://www.ncbi.nlm.nih.gov/pubmed/36339715
http://dx.doi.org/10.3389/fmolb.2022.1034928

Ejemplares similares